Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 27 |
NetGPI | no | yes: 0, no: 27 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 2 |
GO:0031514 | motile cilium | 5 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
GO:0005815 | microtubule organizing center | 2 | 1 |
GO:0005816 | spindle pole body | 3 | 1 |
GO:0036064 | ciliary basal body | 3 | 1 |
GO:0044732 | mitotic spindle pole body | 4 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7XBA2
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 139 | 143 | PF00656 | 0.564 |
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.279 |
CLV_C14_Caspase3-7 | 94 | 98 | PF00656 | 0.309 |
CLV_NRD_NRD_1 | 295 | 297 | PF00675 | 0.551 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.592 |
DOC_MAPK_FxFP_2 | 164 | 167 | PF00069 | 0.440 |
DOC_MAPK_gen_1 | 224 | 233 | PF00069 | 0.313 |
DOC_MAPK_gen_1 | 43 | 52 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 227 | 235 | PF00069 | 0.335 |
DOC_MAPK_MEF2A_6 | 46 | 54 | PF00069 | 0.388 |
DOC_PP4_FxxP_1 | 164 | 167 | PF00568 | 0.420 |
DOC_PP4_FxxP_1 | 235 | 238 | PF00568 | 0.363 |
DOC_PP4_MxPP_1 | 155 | 158 | PF00568 | 0.383 |
LIG_14-3-3_CanoR_1 | 27 | 33 | PF00244 | 0.250 |
LIG_APCC_ABBA_1 | 245 | 250 | PF00400 | 0.419 |
LIG_APCC_ABBA_1 | 52 | 57 | PF00400 | 0.369 |
LIG_Integrin_isoDGR_2 | 254 | 256 | PF01839 | 0.373 |
LIG_LIR_Apic_2 | 163 | 167 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 205 | 210 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.419 |
LIG_REV1ctd_RIR_1 | 76 | 85 | PF16727 | 0.277 |
LIG_SH2_NCK_1 | 309 | 313 | PF00017 | 0.541 |
LIG_SH2_PTP2 | 244 | 247 | PF00017 | 0.419 |
LIG_SH2_SRC | 210 | 213 | PF00017 | 0.380 |
LIG_SH2_SRC | 309 | 312 | PF00017 | 0.429 |
LIG_SH2_STAP1 | 291 | 295 | PF00017 | 0.271 |
LIG_SH2_STAT3 | 172 | 175 | PF00017 | 0.290 |
LIG_SH2_STAT3 | 195 | 198 | PF00017 | 0.360 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.293 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.309 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.148 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 62 | 65 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.295 |
LIG_SH3_3 | 298 | 304 | PF00018 | 0.396 |
LIG_TRFH_1 | 186 | 190 | PF08558 | 0.419 |
LIG_WRC_WIRS_1 | 161 | 166 | PF05994 | 0.444 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.382 |
MOD_CK1_1 | 264 | 270 | PF00069 | 0.433 |
MOD_Cter_Amidation | 215 | 218 | PF01082 | 0.350 |
MOD_Cter_Amidation | 58 | 61 | PF01082 | 0.432 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.385 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.377 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.359 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.389 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.410 |
MOD_GlcNHglycan | 263 | 266 | PF01048 | 0.464 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.428 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.521 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.419 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.234 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.465 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.387 |
MOD_PIKK_1 | 108 | 114 | PF00454 | 0.371 |
MOD_PIKK_1 | 122 | 128 | PF00454 | 0.407 |
MOD_Plk_1 | 81 | 87 | PF00069 | 0.464 |
MOD_Plk_2-3 | 191 | 197 | PF00069 | 0.423 |
MOD_Plk_4 | 264 | 270 | PF00069 | 0.371 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.419 |
TRG_ENDOCYTIC_2 | 309 | 312 | PF00928 | 0.382 |
TRG_Pf-PMV_PEXEL_1 | 150 | 154 | PF00026 | 0.404 |
TRG_Pf-PMV_PEXEL_1 | 296 | 300 | PF00026 | 0.298 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIK8 | Leptomonas seymouri | 25% | 88% |
A0A0N1PBP4 | Leptomonas seymouri | 83% | 100% |
A0A0S4JF26 | Bodo saltans | 61% | 99% |
A0A0S4KIY0 | Bodo saltans | 27% | 88% |
A0A1X0NTG8 | Trypanosomatidae | 26% | 72% |
A0A1X0P1A5 | Trypanosomatidae | 27% | 88% |
A0A1X0P3N0 | Trypanosomatidae | 65% | 94% |
A0A3R7M394 | Trypanosoma rangeli | 64% | 95% |
A0A3R7NAK8 | Trypanosoma rangeli | 25% | 77% |
A0A3S7X3U7 | Leishmania donovani | 28% | 100% |
A0A422P0W0 | Trypanosoma rangeli | 28% | 88% |
A4HCH7 | Leishmania braziliensis | 24% | 76% |
A4HIR9 | Leishmania braziliensis | 27% | 100% |
A4HPP6 | Leishmania braziliensis | 90% | 100% |
A4I615 | Leishmania infantum | 28% | 100% |
A4ID18 | Leishmania infantum | 99% | 99% |
C9ZRE1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 88% |
C9ZSQ2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 72% |
D0A8G8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 97% |
E9AJY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9ATG0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
E9B1A6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
Q4Q137 | Leishmania major | 98% | 100% |
Q4Q6V8 | Leishmania major | 27% | 100% |
Q4QBK7 | Leishmania major | 24% | 76% |
V5BX28 | Trypanosoma cruzi | 26% | 100% |